BAX
NYSE Baxter International Inc.$23.49 ↑ +0.00 (+0.00%) Trading Up from the previous close of $23.49, $0.36 below the day’s high of $23.85
- YTD change
- +22.92%
- vs 20-day SMA
- -1.53%
- vs 200-day SMA
- +12.87%
Price ranges
Price & Performance
+6.81 (+40.83%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 75.3% away from all-time highs of $95.19
- BAX is up 23% since the beginning of the year
- BAX is up 1% over the past 12 months
- BAX is down 9% over the past 1 month
- 5% of all BAX investors are betting against BAX
- Number of investors short BAX has gone down 0% versus last month
BAX reads not so good: price sits above one of the two key moving averages, short interest is falling month over month, the 12-month move is +1.1%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- +0.04%
- vs 8-day SMA
- -0.38%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment sells connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment focuses on the sales of specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
